Can ivermectin help with the flu?
No, ivermectin is not an effective treatment for the flu. It is an antiparasitic drug that has been studied for viral infections in laboratory and small clinical investigations, but clinical trials in people with influenza do not show meaningful benefit in symptoms, viral clearance, or complication prevention. For seasonal influenza, proven options are rest, fluids, antiviral medications prescribed by a clinician, and vaccination for prevention. Ivermectin may be used under medical supervision for approved parasitic indications or in research settings, but it is not recommended for, nor proven to treat, influenza.
How ivermectin works
Intended, approved uses
Ivermectin is an antiparasitic agent approved for specific human and veterinary uses. In humans, it is indicated at approved doses for onchocerciasis (river blindness), lymphatic filariasis, strongyloidiasis, and scabies. It acts primarily by increasing chloride ion influx in invertebrate nerve and muscle cells, causing paralysis and death of parasites. It is not approved as an antiviral or for use against influenza viruses in humans.
| Attribute | Verified Detail | Source Type |
|---|---|---|
| Primary pharmacologic class | Antiparasitic agent (avermectins) | Regulatory labeling |
| Approved human indications | Onchocerciasis, lymphatic filariasis, strongyloidiasis, scabies | Regulatory labeling |
| Mechanism against parasites | Enhances chloride influx, hyperpolarizes nerve and muscle cells | Peer-reviewed pharmacology |
| Authorization status for influenza | Not authorized; no indication for influenza treatment or prevention | Reg agencies (FDA, EMA) |
Evidence in laboratory and animal studies
Laboratory (in vitro) and some animal studies have observed reductions in replication of certain viruses, including influenza viruses, when high concentrations of ivermectin are applied. These findings are mechanistic and do not establish clinical benefit in people. Influenza models in animals involve different strains, routes, and doses than human use; antiviral activity in cells or in mice does not reliably predict effects in patients. Consequently, lab data are considered hypothesis-generating only and do not support use for flu in clinical practice.
Clinical trial findings in people with influenza
Multiple randomized trials in adults and children with influenza have generally found that ivermectin does not reliably reduce symptom duration, viral shedding, or complications when used at doses approved for parasitic infections. Some small studies reported modest reductions in viral detection, but these were not consistently associated with meaningful clinical improvements (e.g., time to symptom resolution, fever trajectory, or lower respiratory outcomes). Overall, guidelines from respiratory and infectious disease societies do not recommend ivermectin for routine management of seasonal or influenza-like illness.
Key trial attributes at a glance
| Metric | Estimate or Range | Context |
|---|---|---|
| Typical studied ivermectin dosing for influenza | Single or multiple doses used in research; often 200–600 mcg/kg | Not regulatory dosing; varies by trial |
| Consistent benefit in symptom duration | No | Trials generally show no clinically significant difference vs placebo |
| Consistent reduction in viral clearance time | No | Some heterogeneous virologic results, not translated to patient-centered outcomes |
| Guideline recommendation for flu | Not recommended | Major respiratory and ID guidelines |
Safety, side effects, and risks
Ivermectin has a known safety profile when used at approved doses for indicated parasitic conditions. Common side effects include dizziness, nausea, diarrhea, and pruritus; serious reactions are rarer but can include severe skin reactions, neurological effects, and CYP3A4 drug interactions. Using doses explored in some influenza studies (often higher or repeated) may increase the risk of adverse events without proven benefit. Self-medication with veterinary formulations is strongly discouraged due to dosing variability and potential toxicity. Always consult a clinician before starting any new medication, especially if you take other drugs or have underlying conditions.
What to do for influenza
If you suspect you have the flu, contact a healthcare provider for evaluation and appropriate management. Proven options include supportive care (rest, hydration, fever control with acetaminophen or ibuprofen as appropriate), prescription antiviral medications (e.g., oseltamivir, baloxavir, zanamivir) when indicated, and vaccination to prevent infection and reduce severity in future seasons. These measures are grounded in robust evidence and are recommended by public health authorities.
Bottom line
There is no reliable evidence that ivermectin helps with the flu. It is not approved or recommended for influenza treatment or prevention. The best ways to manage flu are clinician-guided care, approved antivirals when appropriate, supportive measures, and vaccination. If you are considering ivermectin for any reason, discuss potential risks, benefits, and interactions with your clinician to ensure safe and appropriate use.